Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Aberrantly methylated genes as markers of breast malignancy

Aberrantly methylated genes as markers of breast malignancy

US Patent 7858317 · Granted Dec 28, 2010

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Quantitative multiplex methylation specific PCR method-CMethDNA, reagents, and i2025
Quantitative multiplex methylation specific PCR method-CMethDNA, reagents, and i2025
Quantitative multiplex methylation specific PCR method—cMethDNA, reagents, and i2019
Quantitative multiplex methylation specific PCR method—cMethDNA, reagents, and i2019
Genome-wide methylation analysis and use to identify genes specific to breast ca2019
Genome-wide methylation analysis and use to identify genes specific to breast ca2019
HEYL as a therapeutic target and a diagnostic marker for neoplasia and uses ther2017
Quantitative multiplex methylation-specific PCR2016
Quantitative multiplex methylation-specific PCR2016
Compositions and methods for treatment of tamoxifen resistant breast cancer2015
Quantitative multiplex methylation-specific PCR2014
Quantitative multiplex methylation-specific PCR2014